High-Tech Drugs in Creaky Formulations
Files
Publication date
2017-09
Authors
Herbrink, Maikel
Nuijen, Bastiaan
Schellens, Johannes
Beijnen, Jos
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
Recent literature reviews and registration documents covering novel Signal Transduction Inhibitors in the treatment of cancer paint a picture of inefficiency and variability, where formulation improvements could be valuable. In this article, we discuss apparent drug design flaws as we impose the current standard formulation practice.
Keywords
anticancer drugs, biopharmaceutics, formulation, pharmaceutics, Taverne, SDG 3 - Good Health and Well-being
Citation
Herbrink, M, Nuijen, B, Schellens, J H M & Beijnen, J H 2017, 'High-Tech Drugs in Creaky Formulations', Pharmaceutical Research, vol. 34, no. 9, pp. 1751-1753. https://doi.org/10.1007/s11095-017-2185-4